🔴 BreakingDrug approvalRSSApr 30
FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia
The FDA has approved a new medication called Auvelity to help calm agitation in people with Alzheimer's disease dementia. This is the first non-antipsychotic drug approved for this specific use, meaning it works differently than older medications that were previously used. Agitation is a common and difficult symptom in Alzheimer's patients, so this new option gives doctors another tool to help manage it.
WHY IT MATTERSThis approval offers Alzheimer's patients and caregivers a new treatment option that may help reduce agitation without the side effects associated with traditional antipsychotic medications.